FDA Inspection
Thibiant International, Inc.Thibiant International, Inc. – FDA Inspection, Mar 15, 2018
Record Details
This FDA Inspection record concerns Thibiant International, Inc., with an inspection on March 15, 2018, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 0d00bc22-ad30-468b-bea0-07b5c6d4073e
Inspection Facts
- Inspection number
- 1044966
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.192No written record of investigation
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Thibiant International, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 19, 2014 | VAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
| September 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 25, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Thibiant International, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.